Shree Ganesh Remedies Limited (NSE:SGRL)
India · Delayed Price · Currency is INR 608.65
-20.50 (-3.26%)
At close: Nov 9, 2026
Shree Ganesh Remedies Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 919.58 | 1,093 | 1,086 | 1,259 | 902.2 | 712.88 |
Other Revenue | 0 | - | - | - | - | -0 |
| 919.58 | 1,093 | 1,086 | 1,259 | 902.2 | 712.88 | |
Revenue Growth | -13.63% | 0.64% | -13.74% | 39.54% | 26.56% | 45.24% |
Cost of Revenue | 357 | 454.3 | 391.39 | 582.44 | 476.45 | 373.11 |
Gross Profit | 562.57 | 638.56 | 694.57 | 676.52 | 425.74 | 339.77 |
Selling, General & Admin | 131.73 | 127.77 | 117.27 | 97.65 | 69.93 | 48.46 |
Other Operating Expenses | 164.12 | 147.8 | 174.05 | 154.65 | 115.67 | 107.22 |
Operating Expenses | 399.95 | 380.29 | 386.99 | 313.39 | 220.97 | 189.05 |
Operating Income | 162.63 | 258.27 | 307.58 | 363.12 | 204.78 | 150.72 |
Interest Expense | -23.5 | -34.06 | -20.13 | -5.45 | -0.45 | -1.05 |
Interest & Investment Income | 2.82 | 2.82 | 0.19 | 0.65 | 1.35 | 4.17 |
Currency Exchange Gain (Loss) | 5.41 | 5.41 | 17.44 | 21.46 | 23.34 | 26.58 |
Other Non Operating Income (Expenses) | 9.09 | -0.84 | -0.11 | -0.62 | -0.71 | -0.36 |
EBT Excluding Unusual Items | 156.45 | 231.59 | 304.97 | 379.15 | 228.3 | 180.05 |
Impairment of Goodwill | - | - | - | - | -1.88 | - |
Gain (Loss) on Sale of Investments | 8.63 | 8.63 | 7.7 | 2.45 | - | - |
Gain (Loss) on Sale of Assets | -0.07 | -0.07 | 0.01 | - | 0.19 | - |
Asset Writedown | - | - | - | - | -0.77 | - |
Pretax Income | 165 | 240.15 | 312.68 | 381.6 | 225.84 | 180.05 |
Income Tax Expense | 43.91 | 62.55 | 81.99 | 100.52 | 55.64 | 46.07 |
Net Income | 121.09 | 177.6 | 230.68 | 281.08 | 170.2 | 133.99 |
Net Income to Common | 121.09 | 177.6 | 230.68 | 281.08 | 170.2 | 133.99 |
Net Income Growth | -40.68% | -23.01% | -17.93% | 65.14% | 27.03% | 37.36% |
Shares Outstanding (Basic) | 13 | 13 | 13 | 13 | 12 | 12 |
Shares Outstanding (Diluted) | 13 | 13 | 13 | 13 | 12 | 12 |
Shares Change | 0.06% | -0.06% | 2.08% | 2.49% | 0.42% | 1.82% |
EPS (Basic) | 9.43 | 13.83 | 17.96 | 22.34 | 13.86 | 10.96 |
EPS (Diluted) | 9.43 | 13.83 | 17.96 | 22.34 | 13.86 | 10.96 |
EPS Growth | -40.74% | -22.99% | -19.60% | 61.17% | 26.47% | 34.91% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 60.76 | 71.44 | 74.69 | -6.9 | -345.72 | -19.11 |
Free Cash Flow Per Share | 4.73 | 5.57 | 5.82 | -0.55 | -28.16 | -1.56 |
Dividend Per Share | - | - | - | - | 0.500 | 0.500 |
Dividend Growth | - | - | - | - | 0% | -65.71% |
Gross Margin | 61.18% | 58.43% | 63.96% | 53.74% | 47.19% | 47.66% |
Operating Margin | 17.69% | 23.63% | 28.32% | 28.84% | 22.70% | 21.14% |
Profit Margin | 13.17% | 16.25% | 21.24% | 22.33% | 18.87% | 18.80% |
Free Cash Flow Margin | 6.61% | 6.54% | 6.88% | -0.55% | -38.32% | -2.68% |
EBITDA | 261.63 | 357.9 | 398.43 | 418.85 | 240.76 | 184.71 |
EBITDA Margin | 28.45% | 32.75% | 36.69% | 33.27% | 26.69% | 25.91% |
D&A For EBITDA | 99 | 99.63 | 90.85 | 55.73 | 35.98 | 33.99 |
EBIT | 162.63 | 258.27 | 307.58 | 363.12 | 204.78 | 150.72 |
EBIT Margin | 17.69% | 23.63% | 28.32% | 28.84% | 22.70% | 21.14% |
Effective Tax Rate | 26.61% | 26.05% | 26.22% | 26.34% | 24.64% | 25.59% |
Revenue as Reported | 959.82 | 1,123 | 1,123 | 1,290 | 933.84 | 748.56 |
Advertising Expenses | - | 13.76 | 16.08 | 13.59 | 10.6 | 0.52 |